BioNexus Gene Lab (BGLC) Other Non-Current Assets (2018 - 2026)

BioNexus Gene Lab (BGLC) has 9 years of Other Non-Current Assets data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 4.05% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 4.05% YoY), and the FY2025 full-year result was $1.6 million, up 4.22% from the prior year.
• Other Non-Current Assets rose to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q1 2024 to a low of $849744.0 in Q2 2022.
• A 5-year average of $1.8 million and a median of $1.5 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 119.91% in 2024 and slumped 54.95% in 2025, its largest moves.
• Tracing BGLC's Other Non-Current Assets over 5 years: stood at $1.5 million in 2022, then surged by 119.33% to $3.3 million in 2023, then plunged by 54.91% to $1.5 million in 2024, then increased by 4.22% to $1.6 million in 2025, then grew by 0.88% to $1.6 million in 2026.
• Business Quant data shows BGLC's Other Non-Current Assets at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.